Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Grau

Showing results (201-210 of 504) with videos related to

Pageof 51
Sort By:
Journal of Medicinal Chemistry|May 29, 1999
Novel arylpyrazino[2,3-c][1,2,6]thiadiazine 2,2-dioxides as inhibitors of platelet aggregation. 1. Synthesis and pharmacological evaluationN Campillo, C García, P Goya, et al.
American Journal of Clinical Pathology|October 1, 1993
Secondary (AA) amyloidosis associated with Castleman's disease. Report of two cases and review of the literatureJ Ordi, J M Grau, A Junqué, et al.
Neuromuscular Disorders : NMD|January 1, 1991
Streptococcal myositis as a complication of juvenile dermatomyositisJ Casademont, N Roger, E Pedrol, et al.
Arzneimittel-Forschung|December 1, 1991
Pharmacology of the potent new non-steroidal anti-inflammatory agent aceclofenacM Grau, J Guasch, J L Montero, et al.
Medicina Oral, Patologia Oral Y Cirugia Bucal|June 22, 2024
In vivo study of the behavior of glass ionomer restorations in patients with special needsM Grau-Benítez, F-J Silvestre, A Pascual, et al.
Radiologia|December 18, 2020
Radiologic aspects of COVID-19 pneumonia: outcomes and thoracic complicationsM L Parra Gordo, G Buitrago Weiland, M Grau García, et al.
Medicina Clinica|January 14, 1989
[Chronic lymphatic leukemia and portal hypertension: a causal association?]M Rozman, E Montserrat, M Bruguera, et al.
Medicina Clinica|June 24, 1989
[Myositis with inclusion bodies: a little-known variety of idiopathic inflammatory myopathy]J Casademont Pou, J M Grau Junyent, A Pou Serradell, et al.
JAMA Dermatology|January 19, 2018
Bosentan for Cutaneous Ulcers in Anti-MDA5 DermatomyositisAndrea Combalia, Priscila Giavedoni, Lorena Tamez, et al.
Medicina Clinica|May 15, 1998
[Transient radicular nerve conduction block in patients with intermittent neurogenic claudication]P P Muñoz, J Valls-Solé, L E González, et al.
Pageof 51

Showing results (201-210 of 504) with videos related to

Sort By:
Pageof 51
Journal of Medicinal Chemistry|May 29, 1999
Novel arylpyrazino[2,3-c][1,2,6]thiadiazine 2,2-dioxides as inhibitors of platelet aggregation. 1. Synthesis and pharmacological evaluationN Campillo, C García, P Goya, et al.
American Journal of Clinical Pathology|October 1, 1993
Secondary (AA) amyloidosis associated with Castleman's disease. Report of two cases and review of the literatureJ Ordi, J M Grau, A Junqué, et al.
Neuromuscular Disorders : NMD|January 1, 1991
Streptococcal myositis as a complication of juvenile dermatomyositisJ Casademont, N Roger, E Pedrol, et al.
Arzneimittel-Forschung|December 1, 1991
Pharmacology of the potent new non-steroidal anti-inflammatory agent aceclofenacM Grau, J Guasch, J L Montero, et al.
Medicina Oral, Patologia Oral Y Cirugia Bucal|June 22, 2024
In vivo study of the behavior of glass ionomer restorations in patients with special needsM Grau-Benítez, F-J Silvestre, A Pascual, et al.
Radiologia|December 18, 2020
Radiologic aspects of COVID-19 pneumonia: outcomes and thoracic complicationsM L Parra Gordo, G Buitrago Weiland, M Grau García, et al.
Medicina Clinica|January 14, 1989
[Chronic lymphatic leukemia and portal hypertension: a causal association?]M Rozman, E Montserrat, M Bruguera, et al.
Medicina Clinica|June 24, 1989
[Myositis with inclusion bodies: a little-known variety of idiopathic inflammatory myopathy]J Casademont Pou, J M Grau Junyent, A Pou Serradell, et al.
JAMA Dermatology|January 19, 2018
Bosentan for Cutaneous Ulcers in Anti-MDA5 DermatomyositisAndrea Combalia, Priscila Giavedoni, Lorena Tamez, et al.
Medicina Clinica|May 15, 1998
[Transient radicular nerve conduction block in patients with intermittent neurogenic claudication]P P Muñoz, J Valls-Solé, L E González, et al.
Pageof 51